Majumdar G, Grace R J, Singh A K, Slater N G
UMDS, St Thomas' Campus, London, England.
Leuk Lymphoma. 1992 Dec;8(6):491-3. doi: 10.3109/10428199209051032.
We compared the plasma cell light chain ratios in the bone marrows of 13 patients with multiple myeloma (MM), with those of 13 patients with monoclonal gammopathy of undetermined significance (MGUS). The mean light chain ratio in favour of the paraprotein isotype in the myeloma group was 51.83 (95% confidence limits (CL) 29.52-74.14), while in the MGUS group it was 5.30 (CL 2.07-8.52). The difference between the MGUS and MM groups was significant (p = 0.0005). Neither the bone marrow plasma cell count nor the paraprotein level were significantly correlated with the light chain ratio in either of these two groups. We found a cut-off ratio of 8 to be the most useful in differentiating between myeloma and MGUS. Only one patient with myeloma had a ratio below 8, and one MGUS patient had a ratio above this cut-off point. We conclude that determination of the bone marrow plasma cell light chain ratio is a simple and useful test in differentiating between myeloma and MGUS in difficult cases.
我们比较了13例多发性骨髓瘤(MM)患者与13例意义未明的单克隆丙种球蛋白病(MGUS)患者骨髓中的浆细胞轻链比例。骨髓瘤组中有利于副蛋白同种型的平均轻链比例为51.83(95%置信区间(CL)29.52 - 74.14),而MGUS组为5.30(CL 2.07 - 8.52)。MGUS组和MM组之间的差异具有显著性(p = 0.0005)。在这两组中,骨髓浆细胞计数和副蛋白水平与轻链比例均无显著相关性。我们发现8的比值作为区分骨髓瘤和MGUS最有用。只有1例骨髓瘤患者的比值低于8,1例MGUS患者的比值高于该临界点。我们得出结论,在疑难病例中,测定骨髓浆细胞轻链比例是区分骨髓瘤和MGUS的一项简单且有用的检测方法。